Cen Gao, PhD, is a computational medicinal chemist who leads the development and application of advanced computational strategies to drive therapeutic innovation. With more than 15 years of experience across pharmaceutical and biotech industries, Cen has held research and leadership roles at such companies as Eli Lilly, MOMA Therapeutics and Takeda, contributing to multiple small-molecule oncology and immunology programs and advancing candidates from target identification through clinical proof of concept. His research interest includes integrating computational methods with medicinal chemistry to accelerate discovery efforts.
Key Milestone Expertise in Drug Discovery & Development:
- Hit Identification
- Lead Identification
- Lead Optimization
- Predevelopment (candidate selection)
